Home Physician Specialty Brief Samples Sample: Lung Cancer Brief – Oncology Series

Sample: Lung Cancer Brief – Oncology Series

Sign up for the Oncology Series
Frequency: Weekly


Issue Date: January 19, 2016

Lung Cancer Brief curates research from some of the most authoritative names in health information on the specialty of oncology, focusing on lung cancer.

December 28, 2015 (HealthDay News)


Modifiable Factors Affect Racial Differences in Lung Cancer

Manali I. Patel, M.D., from the Stanford University School of Medicine in California, and colleagues examined racial/ethnic differences in lung cancer incidence and mortality using data from the Women’s Health Initiative Study, which included 129,951 postmenopausal women recruited from 40 clinical centers. Sociodemographic and health information were collected via baseline survey questionnaires.

December 22, 2015 (Medical News Today)


Immunotherapy could benefit patients with advanced non-small-cell lung cancer

The results showed that both doses – the FDA-approved 2 mg/kg dose and an investigational 10 mg/kg dose, each given every 3 weeks – improved median survival in all PD-L1-positive patients, compared with chemotherapy.

September 28, 2015 (Discovery Medicine)


What to Advise to Respiratory Patients Intending to Use Electronic Cigarettes

Alarmist and deeply misleading stories about potential harm of these products have been increasingly fueled by irresponsible science, careless publishing, and credulous journalism. Although ECs are by and large perceived as a much less harmful smoking alternative (Caponnetto et al., 2015; Siegel et al., 2011; Farsalinos et al., 2014), these stories are now spreading fear and confusion by adversely changing the perceptions of the relative risks of smoking and vaping. Therefore, it is likely that more and more respiratory patients using or intending to use ECs will be seeking professional medical advice.


Please enter your comment!
Please enter your name here